Literature DB >> 33793339

Artificial Intelligence in Hypertension: Seeing Through a Glass Darkly.

Sandosh Padmanabhan1, Tran Quoc Bao Tran1, Anna F Dominiczak1.   

Abstract

Hypertension remains the largest modifiable cause of mortality worldwide despite the availability of effective medications and sustained research efforts over the past 100 years. Hypertension requires transformative solutions that can help reduce the global burden of the disease. Artificial intelligence and machine learning, which have made a substantial impact on our everyday lives over the last decade may be the route to this transformation. However, artificial intelligence in health care is still in its nascent stages and realizing its potential requires numerous challenges to be overcome. In this review, we provide a clinician-centric perspective on artificial intelligence and machine learning as applied to medicine and hypertension. We focus on the main roadblocks impeding implementation of this technology in clinical care and describe efforts driving potential solutions. At the juncture, there is a critical requirement for clinical and scientific expertise to work in tandem with algorithmic innovation followed by rigorous validation and scrutiny to realize the promise of artificial intelligence-enabled health care for hypertension and other chronic diseases.

Entities:  

Keywords:  artificial intelligence; blood pressure; clinical trial; hypertension; machine learning

Mesh:

Year:  2021        PMID: 33793339     DOI: 10.1161/CIRCRESAHA.121.318106

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  4 in total

1.  Hypertension Prevalence, Awareness, and Control Among Parents of School-Aged Children in the United Arab Emirates.

Authors:  Syed M Shah; Layla M AlMarzouqi; Romona Devi Govender; Javaid Nauman; Moien A B Khan
Journal:  Patient Prefer Adherence       Date:  2022-05-30       Impact factor: 2.314

2.  Relationship Between Psychosocial Stress and Blood Pressure: The National Heart, Lung, and Blood Institute Family Heart Study.

Authors:  Uzoji Nwanaji-Enwerem; Elijah O Onsomu; Dionne Roberts; Abanish Singh; Beverly H Brummett; Redford B Williams; Jennifer R Dungan
Journal:  SAGE Open Nurs       Date:  2022-06-23

3.  Precision Medicine for Hypertension Patients with Type 2 Diabetes via Reinforcement Learning.

Authors:  Sang Ho Oh; Su Jin Lee; Jongyoul Park
Journal:  J Pers Med       Date:  2022-01-11

Review 4.  Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?

Authors:  Suzanne E Engelen; Alice J B Robinson; Yasemin-Xiomara Zurke; Claudia Monaco
Journal:  Nat Rev Cardiol       Date:  2022-01-31       Impact factor: 49.421

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.